Profiles of HAV-specific IgA production in mucosal immune response to vaccination. Yan Gao Qiudong Su Yao Yi Zhiyuan Jia Hao Wang Xuexin Lu Feng Qiu Shengli Bi 10.1371/journal.pone.0123400.g003 https://plos.figshare.com/articles/figure/_Profiles_of_HAV_specific_IgA_production_in_mucosal_immune_response_to_vaccination_/1377350 <p>HAV IgA was detected by indirect ELISA in (A) vaginal secretions, (B) intestine, (C) respiratory tract and (D) stool homogenates of the mouse groups immunized as indicated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123400#pone.0123400.g002" target="_blank">Fig 2</a>. Each serum effective dose (presented as the GMT) is the reciprocal value of the maximum positive dilution. Error bars represent the SEM. *, <i>P</i><0.05, **, <i>P</i><0.01, ***, <i>P</i><0.001; ns, no significant difference.</p> 2015-04-13 05:01:01 hepatitis protein vaccine hepatitis E virus hav Candidate Mucosal Vaccine sequence Hepatitis E Virus Structural Proteins ifn E infection orf cpg Enhanced Mucosal Immune Responses Induced odn hev reading frame 2 balb tuftsin group tuftsin aa mucosal candidate vaccine virus protein 1 Th 1 response intranasally vp